2017
DOI: 10.1002/cmdc.201700576
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and in vitro Biological Evaluation of Ferrocenyl Side‐Chain‐Functionalized Paclitaxel Derivatives

Abstract: Taxanes, including paclitaxel, are widely used in cancer therapy. In an attempt to overcome some of the disadvantages entailed with taxane chemotherapy, we devised the synthesis of ferrocenyl-functionalized paclitaxel derivatives and studied their biological properties. The cytotoxic activity was measured with a panel of human cancer cell lines of various tissue origin, including multidrug-resistant lines. A structure-activity study of paclitaxel ferrocenylation revealed the N-benzoyl-ferrocenyl-substituted de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 51 publications
0
19
0
Order By: Relevance
“…4f, 15 We have previously demonstrated that even though ferrocenyl paclitaxel analogues are able to stimulate intracellular reactive oxygen species (ROS) production, the redox effects are not as important for their biological activity as their ability to bind tubulin. 16 We have been intrigued, however, by the differential effects exerted by the investigated colchicine analogues on the cells of different tissue origins (see Table 1). It seems plausible that cells derived from organs that are metabolically active or continuously exposed to reactive oxygen species such as liver 17 or lungs 18 and thus producing higher amounts of glutathione and other antioxidant barrier elements are less sensitive to redox active compounds.…”
Section: Reactive Oxygen Species Productionmentioning
confidence: 99%
See 1 more Smart Citation
“…4f, 15 We have previously demonstrated that even though ferrocenyl paclitaxel analogues are able to stimulate intracellular reactive oxygen species (ROS) production, the redox effects are not as important for their biological activity as their ability to bind tubulin. 16 We have been intrigued, however, by the differential effects exerted by the investigated colchicine analogues on the cells of different tissue origins (see Table 1). It seems plausible that cells derived from organs that are metabolically active or continuously exposed to reactive oxygen species such as liver 17 or lungs 18 and thus producing higher amounts of glutathione and other antioxidant barrier elements are less sensitive to redox active compounds.…”
Section: Reactive Oxygen Species Productionmentioning
confidence: 99%
“…C 16 H 18 ORuSi requires C, 54.1; H, 5.1%; IR (KBr) ν max /cm −1 : 3237m, 3110m, 3098m, 2959s, 2900m, 2168m, 2159m, 1629vs, 1590m, 1505w, 1448vs, 1411s, 1392s, 1372vs, 1350m, 1268vs, 1249vs, 1213w, 1102s, 1083vs, 1021s, 1004vs, 894vs, 847vs, 819vs, 761s, 752s, 725s, 705m, 632s, 569m, 482s, 423m; ESI-MS calc. for C 16 3285m, 3106m, 3090s, 2945m, 2922w, 2905w, 2115m, 1683vs, 1637m, 1456vs, 1426m, 1406s, 1396s, 1477s, 1261vs, 1225m, 1187w, 1098s, 1084vs, 1041w, 1029s, 995s, 980s, 904w, 893w, 863m, 843m, 833m, 815vs, 645vs, 606vs, 544m, 530s : 3256vs, 3086s, 2948m, 2939m, 2919m, 2904m, 2869m, 2360w, 2343w, 1671vs, 1453s, 1409s, 1393m, 1379s, 1357m, 1303m, 1290w, 1524s, 1213m, 1101s, 1096m, 1050m, 1026m, 1000m, 982m, 892m, 876w, 869w, 821s, 787w, 752w, 684s, 525w, 514m, 460s, 434s, 418m; ESI-MS calc. for C 17 H 18 ORu 340.0 (M + ) found 341.0 ((M + H) + , 100%); 1 H NMR (CDCl 3 ) δ 5.10 (t, J = 1.7 Hz, 2H, Cp), 4.77 (t, J = 1.…”
Section: General Procedures Asynthesis Of ϖ-Alkynoylruthenocenes 19-23mentioning
confidence: 99%
“…The cell cycle analysis was performed as described previously [33]. Briefly, exponentially growing cells were treated with EPE at the desired concentration for 24 h. Then, cells were harvested by trypsinization, washed twice in ice-cold PBS, and fixed in 70% ethanol.…”
Section: Cell-cycle Analysismentioning
confidence: 99%
“…The last decades have brought huge progress in the development of new metallocenyl, mainly ferrocenyl and to al esser extent ruthenocenyl, conjugates with various types of bioactive compounds. [27] Recently,w ea nd others reported the synthesis andb iological activity of ferrocenyl conjugates acting as microtubule stabilizing [28] or destabilizing [29] agents. Metallocenyl conjugates with other tubulin-binding molecules were also studied.…”
Section: Introductionmentioning
confidence: 99%